Soros Fund Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Soros Fund Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,700,001	Closed	-$66.9M	–	259
2023 Q2	$66.9M	Buy	+1,700,001	New	+$60M	1.04%	28

Soros Fund Management's ISEE Position: Q3 2023 in Review

Soros Fund Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,700,001 shares — an estimated $66.9M sold.

Soros Fund Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $66.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Soros Fund Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Soros Fund Management sold 1,700,001 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $66.9M.
Soros Fund Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Soros Fund Management's IVERIC bio, Inc. Common Stock position peaked at $66.9M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Soros Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.